Primary Peritoneal Carcinoma Active Not Recruiting Phase 2 Trials for Enzalutamide (DB08899)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01974765Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior TherapiesTreatment